Aurobindo Pharma Receives US FDA Approval For Generic Precedex

Aurobindo Pharma Receives US FDA Approval For Generic Precedex

By, Admin 10 December 2020

Aurobindo Pharma Limited has received final approval from the US Food & Drug Administration (FDA) to manufacture and market dexmedetomidine hydrochloride in 0.9% sodium chloride injection, 200 µg/50 mL and 400 µg/100 mL single dose flexible containers (bags).Aurobindo's dexmedetomidine HCl in 0.9% sodium chloride injection is a therapeutic equivalent generic version of Hospira's Precedex in 0.9% sodium chloride injection.The product will be launched in January 2021.Dexmedetomidine hydrochloride in 0.9% sodium chloride injection is a relatively selective alpha2 - adrenergic agonist indicated for a) sedation of initially intubated and mechanically ventilated patients during treatment in an intensive care setting; b) sedation of non-intubated patients prior to and/or during surgical and other procedures.The approved product has an estimated market size of US$ 228 million for the twelve months ending October 2020, according to IQVIA.This is the 79th ANDA to be approved out of Unit IV formulation facility in Hyderabad, India used for manufacturing injectable & ophthalmic products.Aurobindo now has a total of 459 ANDA approvals (431 Final approvals and 28 tentative approvals) from US FDA.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!